Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Asia Pacific Helicobacter Pylori Diagnostics Market Size, Share & Industry Trends Analysis Report By Test Type (Non-invasive and Invasive), By End User, By Method (Laboratory Based Test and Point of Care Test), By Country and Growth Forecast, 2023 - 2030

Published Date : 30-Jun-2023

Pages: 88

Formats: PDF

The Asia Pacific Helicobacter Pylori Diagnostics Market would witness market growth of 6.3% CAGR during the forecast period (2023-2030).

The main factors driving the market are the increased prevalence of infectious diseases and people's growing knowledge of infections. The most prevalent infectious disorders brought on by bacteria are gonorrhea, chlamydia, tuberculosis, various STDs, gastroenteritis, and urinary tract infections (UTIs).

An immunoassay test uses biochemistry to determine the amount and concentration of an analyte. Large proteins, antibodies a person has developed in response to an infection, or tiny molecules can all be analytes. Immunoassays are very precise and sensitive. Their high specificity is due to the reagents they use, which include antibodies and purified antigens. This assay can be used to directly diagnose a disease by assessing the presence of antigens. Additionally, employing an antibody or antigen as a biorecognition agent is a highly selective bioanalytical approach that assesses the presence or quantity of analytes ranging from tiny molecules to macromolecules in solution.

It stated that a major portion of cases of gastritis caused by Helicobacter pylori positivity is often consistent with the prevalence of the infection. Since these infections are typically detected using immunoassays, rising rates of gastritis and Helicobacter pylori infection are expected to drive segment growth during the projection period.

The likelihood of survival for stomach cancer substantially depends on the stage or phase of the disease at the time of diagnosis. The likelihood of survival rises with the early stages of sickness development. Most instances identified at a later stage of the disease in the Asia Pacific are in senior patients. The region's aging population rise is strongly correlated with increased cases of stomach cancer. Due to this factor and the growing need for early identification driven by increased health awareness, the market will grow over the forecast period in the APAC.

The China market dominated the Asia Pacific Helicobacter Pylori Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $62.2 Million by 2030. The Japan market is exhibiting a CAGR of 5.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.9% during (2023 - 2030).

Based on Test Type, the market is segmented into Non-invasive and Invasive. Based on End User, the market is segmented into Diagnostics Laboratories, Hospitals, and Others. Based on Method, the market is segmented into Laboratory Based Test and Point of Care Test. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Helicobacter Pylori Diagnostics Market is Projected to reach USD 805.9 Million by 2030, at a CAGR of 5.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Biohit Oyj, Abbott Laboratories, Quidel Corporation, Gulf Coast Scientific, Inc. (Gulf Coast Medical Center), Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Avanos Medical, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Test Type

  • Non-invasive
  • Invasive

By End User

  • Diagnostics Laboratories
  • Hospitals
  • Others

By Method

  • Laboratory Based Test
  • Point of Care Test

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Cardinal Health, Inc.
  • Biohit Oyj
  • Abbott Laboratories
  • Quidel Corporation
  • Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
  • Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
  • Avanos Medical, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • F.Hoffmann-La Roche Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Helicobacter Pylori Diagnostics Market, by Test Type
1.4.2 Asia Pacific Helicobacter Pylori Diagnostics Market, by End User
1.4.3 Asia Pacific Helicobacter Pylori Diagnostics Market, by Method
1.4.4 Asia Pacific Helicobacter Pylori Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type
3.1 Asia Pacific Non-invasive Market by Country
3.2 Asia Pacific Invasive Market by Country

Chapter 4. Asia Pacific Helicobacter Pylori Diagnostics Market by End User
4.1 Asia Pacific Diagnostics Laboratories Market by Country
4.2 Asia Pacific Hospitals Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Helicobacter Pylori Diagnostics Market by Method
5.1 Asia Pacific Laboratory Based Test Market by Country
5.2 Asia Pacific Point of Care Test Market by Country

Chapter 6. Asia Pacific Helicobacter Pylori Diagnostics Market by Country
6.1 China Helicobacter Pylori Diagnostics Market
6.1.1 China Helicobacter Pylori Diagnostics Market by Test Type
6.1.2 China Helicobacter Pylori Diagnostics Market by End User
6.1.3 China Helicobacter Pylori Diagnostics Market by Method
6.2 Japan Helicobacter Pylori Diagnostics Market
6.2.1 Japan Helicobacter Pylori Diagnostics Market by Test Type
6.2.2 Japan Helicobacter Pylori Diagnostics Market by End User
6.2.3 Japan Helicobacter Pylori Diagnostics Market by Method
6.3 India Helicobacter Pylori Diagnostics Market
6.3.1 India Helicobacter Pylori Diagnostics Market by Test Type
6.3.2 India Helicobacter Pylori Diagnostics Market by End User
6.3.3 India Helicobacter Pylori Diagnostics Market by Method
6.4 South Korea Helicobacter Pylori Diagnostics Market
6.4.1 South Korea Helicobacter Pylori Diagnostics Market by Test Type
6.4.2 South Korea Helicobacter Pylori Diagnostics Market by End User
6.4.3 South Korea Helicobacter Pylori Diagnostics Market by Method
6.5 Singapore Helicobacter Pylori Diagnostics Market
6.5.1 Singapore Helicobacter Pylori Diagnostics Market by Test Type
6.5.2 Singapore Helicobacter Pylori Diagnostics Market by End User
6.5.3 Singapore Helicobacter Pylori Diagnostics Market by Method
6.6 Malaysia Helicobacter Pylori Diagnostics Market
6.6.1 Malaysia Helicobacter Pylori Diagnostics Market by Test Type
6.6.2 Malaysia Helicobacter Pylori Diagnostics Market by End User
6.6.3 Malaysia Helicobacter Pylori Diagnostics Market by Method
6.7 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market
6.7.1 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type
6.7.2 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by End User
6.7.3 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Method

Chapter 7. Company Profiles
7.1 Biohit Oyj
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.2 Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
7.2.1 Company Overview
7.3 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Recent strategies and developments:
7.3.3.1 Acquisition and Mergers:
7.4 Avanos Medical, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Thermo Fisher Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 F. Hoffmann-La Roche Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Quidel Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. Bio-Rad laboratories, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 Asia Pacific Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Non-invasive Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Non-invasive Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Invasive Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Invasive Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Diagnostics Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Diagnostics Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Laboratory Based Test Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Laboratory Based Test Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Point of Care Test Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Point of Care Test Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Helicobacter Pylori Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Helicobacter Pylori Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 25 China Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 26 China Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 27 China Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 28 China Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 29 China Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 30 China Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 31 China Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 32 China Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 33 Japan Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 34 Japan Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 35 Japan Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 36 Japan Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 37 Japan Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 38 Japan Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 39 Japan Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 40 Japan Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 41 India Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 42 India Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 43 India Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 44 India Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 45 India Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 46 India Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 47 India Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 48 India Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 49 South Korea Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 50 South Korea Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 51 South Korea Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 52 South Korea Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 53 South Korea Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 54 South Korea Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 55 South Korea Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 56 South Korea Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 57 Singapore Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 58 Singapore Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 59 Singapore Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 60 Singapore Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 61 Singapore Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 62 Singapore Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 63 Singapore Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 64 Singapore Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 65 Malaysia Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 66 Malaysia Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 67 Malaysia Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 68 Malaysia Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 69 Malaysia Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 70 Malaysia Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 71 Malaysia Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 72 Malaysia Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 73 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
TABLE 74 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
TABLE 75 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
TABLE 77 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 79 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
TABLE 81 Key Information – Biohit Oyj
TABLE 82 Key Information – Gulf Coast Scientific, Inc.
TABLE 83 Key Information – Meridian Bioscience, Inc.
TABLE 84 Key Information – Avanos Medical, Inc.
TABLE 85 Key Information – Abbott Laboratories
TABLE 86 Key Information – Thermo Fisher Scientific, Inc.
TABLE 87 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 88 key information – Quidel Corporation
TABLE 89 key information – Cardinal Health, Inc.
TABLE 90 Key Information – Bio-Rad Laboratories, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Helicobacter Pylori Diagnostics Market share by Test Type, 2022
FIG 3 Asia Pacific Helicobacter Pylori Diagnostics Market share by Test Type, 2030
FIG 4 Asia Pacific Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2030, USD Million
FIG 5 Asia Pacific Helicobacter Pylori Diagnostics Market share by End User, 2022
FIG 6 Asia Pacific Helicobacter Pylori Diagnostics Market share by End User, 2030
FIG 7 Asia Pacific Helicobacter Pylori Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 8 Asia Pacific Helicobacter Pylori Diagnostics Market share by Method, 2022
FIG 9 Asia Pacific Helicobacter Pylori Diagnostics Market share by Method, 2030
FIG 10 Asia Pacific Helicobacter Pylori Diagnostics Market by Method, 2019 - 2030, USD Million
FIG 11 Asia Pacific Helicobacter Pylori Diagnostics Market share by Country, 2022
FIG 12 Asia Pacific Helicobacter Pylori Diagnostics Market share by Country, 2030
FIG 13 Asia Pacific Helicobacter Pylori Diagnostics Market by Country, 2019 - 2030, USD Million
FIG 14 Swot analysis: Abbott laboratories
FIG 15 Swot analysis: thermo fisher scientific, inc.

Purchase Full Report of
Asia Pacific Helicobacter Pylori Diagnostics Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL